Apurva Jain

Apurva Jain

Auto-generated profile, based on publicly available information

Apurva Jain

Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in JCO Precision Oncology
Verified
Journal Article
Open access
LPLeontios Pappas
Leontios Pappas
IBIslam Baiev
Islam Baiev
SRStephanie Reyes
Stephanie Reyes
ABAndrea Grace Bocobo
Andrea Grace Bocobo
AJApurva Jain
Apurva Jain
LGLipika Goyal
Lipika Goyal
PURPOSE: Increased awareness of the distinct tumor biology for adolescents and young adults (AYAs) with cancer has led to improvement in outcomes for this population. However, in cholangiocarcinoma (CCA), a paucity of data exist on the AYA population. To our knowledge, we present the largest study to date on AYA disease biology, treatment patterns, and survival outcomes in CCA. METHODS: A multi-institutional cohort of patients with CCA diagnosed with intrahepatic cholangiocarcinoma (ICC) or extrahepatic cholangiocarcinoma (ECC) was used for analysis. Retrospective chart review was conducted on patients who were 50 years old and younger (young; n = 124) and older than 50 years (older; n = 723). RESULTS: Among 1,039 patients screened, 847 patients met eligibility (72% ICC, 28% ECC). Young patients had a larger median tumor size at resection compared with older patients (4.2 v 3.6 cm; P = .048), more commonly had N1 disease (65% v 43%; P = .040), and were more likely to receive adjuvant therapy (odds ratio, 4.0; 95% CI, 1.64 to 9.74). Tumors of young patients were more likely to harbor an FGFR2 fusion, BRAF mutation, or ATM mutation ( P < .05 for each). Young patients were more likely to receive palliative systemic therapy (96% v 69%; P < .001), targeted therapy (23% v 8%; P < .001), and treatment on a clinical trial (31% v 19%; P = .004). Among patients who presented with advanced disease, young patients had a higher median overall survival compared with their older counterparts (17.7 v 13.5 months; 95% CI, 12.6 to 22.6 v 11.4 to 14.8; P = .049). CONCLUSION: Young patients with CCA had more advanced disease at resection, more commonly received both adjuvant and palliative therapies, and demonstrated improved survival compared with older patients. Given the low clinical trial enrollment and poor outcomes among some AYA cancer populations, data to the contrary in CCA are highly encouraging.

31 May 2022 in International Journal of Advanced Research
Verified
Journal Article
Open access
JKJitendra Kumar
Jitendra Kumar
AJApurva Jain
Apurva Jain
RKRashmi Kumari
Rashmi Kumari
Purpose -To study the clinical profile of patients of panophthalmitis presenting to the tertiary health care centre. Methods-This was a prospective observational study that involved25 patients with panophthalmitis complaining of blurring of vision, redness, pain, purulent discharge, photophobia and eyelid swelling. Results-There were 18 males and 7 females and the age group taken was 30 to 75 years.14 patients belonged to the age group of 30 to 45 years, out of which 10 were males and 4 were females. 7 patients belonged to age group of 46 to 60 years, out of which 5 were males and 2 were females. 4 patients belonged to the age group of 61 to 75 years, out of which 3 were males and 1 was female. Most common presentation in panophthalmitis patients is loss of vision in 88% patients followed by redness in 76% patients, pain in 72% patients, purulent discharge in 68% patients,photophobia in 55% patients and eyelid swelling in 48% patients. Majority of patients belong to low socioeconomic class. The most common cause was post traumatic followed by post operative and some endogenous infections spread through hematogenous route. Of the 25 cases of culture-positive panophthalmitis, 18 cases (75%) had bacterial growth and 7 cases (25%) had fungal growth. In post-traumaticpanophthalmitis, Gram-positive bacteria were the predominant species, followed by Gram-negative bacteria and fungi. In endogenous panophthalmitis, Gram-negative bacteria were the predominant species, followed by fungi and Gram-positive bacteria. In postsurgical panophthalmitis, all infections were bacterial. Conclusion-Panophthalmitis is a dreaded ocular disease and tends to occur more commonly in males of 30 to 45 years agegroup. Most common presentation of panophthalmitis is loss of vision followed by redness, pain, purulent discharge, photophobia and eyelid swelling and signs include eyelid edema, hypopyon, circumcilliary congestion, corneal haze and ulcer and vitreous haze. Most common cause of panophthalmitis was post traumatic with gram positive bacteria followed by endogenous causes with gram negative bacteria and post operative cases with gram positive bacteria isolated.